Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   Working Capital/Sales(x) 1.573.273.576.677.14

What is the latest Working Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Working Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) is 1.57 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.57
Mar20233.27
Mar20223.57
Mar20176.67
Mar20167.14

How is Working Capital/Sales of SYNCOM FORMULATIONS (INDIA) Trending?

Years Working Capital/Sales % Change
Mar2024 1.57
-51.99
Mar2023 3.27
-8.40
Mar2022 3.57
-46.48
Mar2017 6.67
-6.58
Mar2016 7.14 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Working Capital/Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,621.5 Cr -5.7% -8.5% 12.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-5.7%

-8.5%

12.1%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses